Aditx Therapeutics Inc., of Loma Linda, Calif., appointed Laura Anthony to its board and chair of its corporate governance committee. She will also serve on the audit and compensation committee.
Epimab Biotherapeutics Inc., of Shanghai, appointed Mark Smyth its scientific advisory board.
Mesoblast Ltd., of Melbourne, Australia, appointed Dagmar Rosa-Bjorkeson chief operating officer.
Protara Therapeutics Inc., of New York, Barry P. Flannelly to its board.
Xilio Therapeutics Inc., of Waltham, Mass., appointed Paul J. Clancy to its board.